Provided by Tiger Trade Technology Pte. Ltd.

JIUYUAN GENE

5.285
-0.115-2.13%
Volume:8K
Turnover:40.36K
Market Cap:1.27B
PE:8.03
High:5.395
Open:5.395
Low:5.285
Close:5.400
52wk High:14.801
52wk Low:4.600
Shares:240.00M
HK Float Shares:240.00M
Volume Ratio:0.87
T/O Rate:0.00%
Dividend:0.07
Dividend Rate:1.26%
EPS(LYR):0.658
ROE:8.50%
ROA:4.52%
PB:0.64
PE(LYR):8.03
PS:0.84

Loading ...

JIUYUAN GENE Finalises Corporate Rebranding to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Bulletin Express
·
May 11

Jiuyuan Genetic Biopharm Gets HKEX Nod to Convert, List 136 Million Shares

MT Newswires Live
·
May 11

JIUYUAN GENE Receives Listing Approval for H-Share Full Circulation Reform

Stock News
·
May 08

Hangzhou Jiuyuan Gene wins HKEX listing approval for 136,302,015 converted H shares

Reuters
·
May 08

Jiuyuan Gene Updates on Public Float: Currently 22.22%, Full-Circulation Plan Targets 31.13% by Q2 2026

Bulletin Express
·
May 06

JIUYUAN GENE Announces Public Float at 22.22%, Aims to Restore Compliance by Q2 2026

Stock News
·
May 06

Jiuyuan Genetic Biopharmaceutical Gets China Nod for Weight Management Drug Trial

MT Newswires Live
·
Apr 28

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtained Clinical Trial Approval in China

THOMSON REUTERS
·
Apr 28

BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China

Reuters
·
Apr 28

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtains Nmpa Approval to Conduct Clinical Trials in China

THOMSON REUTERS
·
Apr 28

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Stock News
·
Apr 25

Jiuyuan Gene Publishes 2025 Results, Declares RMB0.57 Dividend per 10 Shares and Seeks to Abolish Supervisory Committee

Bulletin Express
·
Apr 24

Jiuyuan Gene releases AGM agenda outlining 17 resolutions, including profit distribution plan and governance restructuring

Bulletin Express
·
Apr 24

Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026

Bulletin Express
·
Apr 23

JIUYUAN GENE to Distribute Final Dividend of RMB 0.57 per 10 Shares on July 30

Stock News
·
Apr 23

Hangzhou Jiuyuan Gene Engineering proposes final dividend of RMB 0.57 per 10 shares

Reuters
·
Apr 23

Jiuyuan Gene releases 2025 ESG report: 19.67 kt CO₂e emitted, 1,794-strong workforce and tighter 2026 resource-efficiency targets

Bulletin Express
·
Apr 23

Hangzhou Jiuyuan Gene Engineering publishes 2025 ESG report

Reuters
·
Apr 23

九源基因2025年营收同比降4.59%至人民币13.063亿元,聚焦创新驱动与全球化战略

Bulletin Express
·
Apr 23

Jiuyuan Gene Updates Market on Public Float Restoration; Expects Compliance by Q2 2026

Bulletin Express
·
Apr 08